Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C David Mazer

Showing results (151-160 of 282) with videos related to

Pageof 29
Sort By:
The Journal of Extra-Corporeal Technology|July 23, 2010
The effect of the perioperative blood transfusion and blood conservation in cardiac surgery Clinical Practice Guidelines of the Society of Thoracic Surgeons and the Society of Cardiovascular Anesthesiologists upon clinical practicesDonald S Likosky, Daniel C FitzGerald, Robert C Groom, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|May 12, 2016
Functional and anatomical evidence of cerebral tissue hypoxia in young sickle cell anemia miceLindsay S Cahill, Lisa M Gazdzinski, Albert Ky Tsui, et al.
Nephron. Physiology|December 5, 2012
Response of the renal inner medulla to hypoxia: possible defense mechanismsNamhee Kim, Laura Voicu, Gregory M T Hare, et al.
European Heart Journal|August 15, 2018
Restrictive compared with liberal red cell transfusion strategies in cardiac surgery: a meta-analysisNadine Shehata, Nikhil Mistry, Bruno R da Costa, et al.
BMJ Open|July 2, 2017
Defining clinically important perioperative blood loss and transfusion for the Standardised Endpoints for Perioperative Medicine (StEP) collaborative: a protocol for a scoping reviewJustyna Bartoszko, Leon Vorobeichik, Mohandas Jayarajah, et al.
Trials|October 29, 2025
POINTER: study protocol for a phase 2b, randomised, placebo-controlled, double-blind, parallel group dose-finding clinical study to evaluate the efficacy of RMC-035 on renal function and safety, in participants at high risk for kidney injury, following open-chest cardiac surgeryAlexander Zarbock, Christian Strauss, Maxime Laflamme, et al.
British Journal of Anaesthesia|March 29, 2020
Short-term outcomes of combined neuraxial and general anaesthesia versus general anaesthesia alone for elective open abdominal aortic aneurysm repair: retrospective population-based cohort study<sup>†</sup>Konrad Salata, Faraj W Abdallah, Mohamad A Hussain, et al.
Journal of the American Heart Association|December 24, 2022
Transfusion Thresholds for Acute Coronary Syndromes-Insights From the TRICS-III Randomized Controlled Trial, Systematic Review, and Meta-AnalysisNikhil Mistry, Gregory M T Hare, Nadine Shehata, et al.
Diabetes, Obesity & Metabolism|April 1, 2020
Empagliflozin reduces the risk of mortality and hospitalization for heart failure across Thrombolysis In Myocardial Infarction Risk Score for Heart Failure in Diabetes categories: Post hoc analysis of the EMPA-REG OUTCOME trialSubodh Verma, Abhinav Sharma, Bernard Zinman, et al.
Diabetes, Obesity & Metabolism|May 29, 2023
The association between anthropometric indicators of obesity and cardiac reverse remodelling with empagliflozin in patients with type 2 diabetes and coronary artery diseasePankaj Puar, Shamon Ahmed, Makoto Hibino, et al.
Pageof 29

Showing results (151-160 of 282) with videos related to

Sort By:
Pageof 29
The Journal of Extra-Corporeal Technology|July 23, 2010
The effect of the perioperative blood transfusion and blood conservation in cardiac surgery Clinical Practice Guidelines of the Society of Thoracic Surgeons and the Society of Cardiovascular Anesthesiologists upon clinical practicesDonald S Likosky, Daniel C FitzGerald, Robert C Groom, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|May 12, 2016
Functional and anatomical evidence of cerebral tissue hypoxia in young sickle cell anemia miceLindsay S Cahill, Lisa M Gazdzinski, Albert Ky Tsui, et al.
Nephron. Physiology|December 5, 2012
Response of the renal inner medulla to hypoxia: possible defense mechanismsNamhee Kim, Laura Voicu, Gregory M T Hare, et al.
European Heart Journal|August 15, 2018
Restrictive compared with liberal red cell transfusion strategies in cardiac surgery: a meta-analysisNadine Shehata, Nikhil Mistry, Bruno R da Costa, et al.
BMJ Open|July 2, 2017
Defining clinically important perioperative blood loss and transfusion for the Standardised Endpoints for Perioperative Medicine (StEP) collaborative: a protocol for a scoping reviewJustyna Bartoszko, Leon Vorobeichik, Mohandas Jayarajah, et al.
Trials|October 29, 2025
POINTER: study protocol for a phase 2b, randomised, placebo-controlled, double-blind, parallel group dose-finding clinical study to evaluate the efficacy of RMC-035 on renal function and safety, in participants at high risk for kidney injury, following open-chest cardiac surgeryAlexander Zarbock, Christian Strauss, Maxime Laflamme, et al.
British Journal of Anaesthesia|March 29, 2020
Short-term outcomes of combined neuraxial and general anaesthesia versus general anaesthesia alone for elective open abdominal aortic aneurysm repair: retrospective population-based cohort study<sup>†</sup>Konrad Salata, Faraj W Abdallah, Mohamad A Hussain, et al.
Journal of the American Heart Association|December 24, 2022
Transfusion Thresholds for Acute Coronary Syndromes-Insights From the TRICS-III Randomized Controlled Trial, Systematic Review, and Meta-AnalysisNikhil Mistry, Gregory M T Hare, Nadine Shehata, et al.
Diabetes, Obesity & Metabolism|April 1, 2020
Empagliflozin reduces the risk of mortality and hospitalization for heart failure across Thrombolysis In Myocardial Infarction Risk Score for Heart Failure in Diabetes categories: Post hoc analysis of the EMPA-REG OUTCOME trialSubodh Verma, Abhinav Sharma, Bernard Zinman, et al.
Diabetes, Obesity & Metabolism|May 29, 2023
The association between anthropometric indicators of obesity and cardiac reverse remodelling with empagliflozin in patients with type 2 diabetes and coronary artery diseasePankaj Puar, Shamon Ahmed, Makoto Hibino, et al.
Pageof 29